David J. Vaughn
University of Pennsylvania(US)
Publications by Year
Research Areas
Testicular diseases and treatments, Bladder and Urothelial Cancer Treatments, Cancer Treatment and Pharmacology, Urinary and Genital Oncology Studies, Prostate Cancer Treatment and Research
Most-Cited Works
- → Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma(2017)3,353 cited
- → American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects(2007)795 cited
- → Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone(2011)619 cited
- → Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up(2019)478 cited
- → Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens(2010)453 cited
- → Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology(2019)443 cited